Dr. Stanislav Lazarev, MD

2019 Medicare Procedure Volume

The top procedures that Dr. Stanislav Lazarev, MD treated as a radiation oncologist in New York, NY during 2019 were radiation therapy.

Volume of procedures performed by Dr. Stanislav Lazarev, MD for Medicare patients.

Conditions of Medicare patients treated by Dr. Stanislav Lazarev, MD in 2019

The most common conditions of Medicare patients that Dr. Stanislav Lazarev, MD treated during 2019 were hypertension, high cholesterol, ischemic heart disease and cancer.

2020 Medicare Procedure Volume

The top procedures that Dr. Stanislav Lazarev, MD treated as a radiation oncologist in New York, NY during 2020 were radiation therapy.

Volume of procedures performed by Dr. Stanislav Lazarev, MD for Medicare patients.

2020 Medicare Patient Data

Information about Medicare patients treated by Dr. Stanislav Lazarev, MD.

Conditions of Medicare patients treated by Dr. Stanislav Lazarev, MD in 2020

The most common conditions of Medicare patients that Dr. Stanislav Lazarev, MD treated during 2020 were hypertension, high cholesterol, cancer and ischemic heart disease.

2021 Medicare Procedure Volume

The top procedures that Dr. Stanislav Lazarev, MD treated as a radiation oncologist in New York, NY during 2021 were radiation therapy.

Volume of procedures performed by Dr. Stanislav Lazarev, MD for Medicare patients.

Average Medicare Procedure Volume From 2019 - 2021

Volume of procedures performed by Dr. Stanislav Lazarev, MD for Medicare patients.

The highest averages for the top procedures that Dr. Stanislav Lazarev, MD treated as a radiation oncologist in New York, NY were radiation therapy.

Average Medicare Patient Data From 2019 - 2021

Information about Medicare patients treated by Dr. Stanislav Lazarev, MD.

Average of Total of Conditions of Medicare patients treated by Dr. Stanislav Lazarev, MD From 2019 - 2021

The highest averages of the most common conditions of Medicare patients that Dr. Stanislav Lazarev, MD treated were hypertension, high cholesterol, cancer and ischemic heart disease.